Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Recombinant fusion protein consisting of the extracellular portion of human activin receptor IIB linked to the human IgG1 Fc domain

EU orphan designation number: EU/3/10/812
Active ingredient: Recombinant fusion protein consisting of the extracellular portion of human activin receptor IIB linked to the human IgG1 Fc domain
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Shire Pharmaceuticals Ireland Limited
5 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Orphan designation EMA/OD/085/10 (2010)8597 of 26/11/2010
18/05/2011 Transfer of orphan designation EMA/OD/085/10/T/01 (2011)3484 of 13/05/2011
30/01/2015 Removal of orphan designation from Community Register